Share
FRONTLINE Editor-in-Chief and Executive Producer Raney Aronson-Rath sits down with journalists and filmmakers for probing conversations about the investigative journalism that drives each FRONTLINE documentary and the stories that shape our time. Produced at FRONTLINE’s headquarters at GBH and powered by PRX. The FRONTLINE Dispatch is made possible by the Abrams Foundation Journalism Initiative.
…
continue reading
Manage episode 522034691 series 1415376
Content provided by 95bFM: The Wire. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by 95bFM: The Wire or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Starting in December, the government is banning new prescriptions of puberty blockers to adolescents.
However, concerns have been raised about the effect this ban will have on the mental health of these individuals – research suggests that the medication reduces mental health distress in transgender youth, a community that is already vulnerable. Banning the drug may have adverse affects in this same vein.
Monday Wire Producer Alex spoke to Professor in Pediatric Endocrinology at the Liggins Institute at the University of Auckland, Paul Hofman, about the ban, and what it means for the mental health of our transgender and gender dysphoric youth.
1172 episodes
))
